Adenosine A2A Receptor Antagonists Act at the Hyperoxic Phase to Confer Protection Against Retinopathy

Molecular Medicine - United States
doi 10.1186/s10020-018-0038-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Adenosine A2a Receptor Antagonists Attenuate Striatal Adaptations Following Dopamine Depletion

Neurobiology of Disease
Neurology
2012English

Past, Present and Future of A2A Adenosine Receptor Antagonists in the Therapy of Parkinson's Disease

Pharmacology and Therapeutics
Pharmacology
2011English

ACE2 and Ang-(1-7) Confer Protection Against Development of Diabetic Retinopathy

Molecular Therapy
Molecular MedicineMolecular BiologyPharmacologyMedicineGeneticsDrug Discovery
2012English

Adenosine A1-A2a Receptor-Receptor Interaction: Contribution to Guanosine-Mediated Effects

Cells
2019English

Adenosine Through the A2A Adenosine Receptor Increases IL-1β in the Brain Contributing to Anxiety

Brain, Behavior, and Immunity
EndocrineImmunologyBehavioral NeuroscienceAutonomic Systems
2014English

The A2a-Adenosine Receptor: A GPCR With Unique Features?

British Journal of Pharmacology
Pharmacology
2009English

Predictions for Cholesterol Interaction Sites on the A2A Adenosine Receptor

Biophysical Journal
Biophysics
2013English

17β-Estradiol Ameliorates Oxygen-Induced Retinopathy in the Early Hyperoxic Phase

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2015English

A2A Adenosine Receptor Functional States Characterized by 19f-NMR

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy